American Wealth Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-900
Closed -$4.66K 96
2025
Q4
$4.66K Hold
900
﹤0.01% 106
2025
Q3
$3.8K Buy
+900
New +$4.18K ﹤0.01% 107

Other funds holding ORGO

American Wealth Advisors's ORGO Position: Q1 2026 in Review

American Wealth Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 900 shares — an estimated $4.66K sold.

American Wealth Advisors first reported a position in ORGO in Q3 2025 and held it in 2 quarters. The position peaked at $4.66K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • American Wealth Advisors reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • American Wealth Advisors sold 900 Organogenesis Holdings shares in Q1 2026, an estimated $4.66K.
  • American Wealth Advisors first reported a position in Organogenesis Holdings in Q3 2025 and held it in 2 quarters.
  • American Wealth Advisors's Organogenesis Holdings position peaked at $4.66K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on American Wealth Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.